Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Market Cap	44.77B -0.7%
Revenue (ttm)	84.74B +1.5%
Net Income	3.26B -12.8%
EPS	2.01 -12.8%
Shares Out	n/a
PE Ratio	13.71
Forward PE	14.27
Dividend	0.88 (4.66%)
Ex-Dividend Date	Aug 29, 2025

Volume	609,274
Average Volume	787,030
Open	19.05
Previous Close	18.81
Day's Range	18.68 - 19.05
52-Week Range	15.76 - 20.40
Beta	0.29
RSI	49.17
Earnings Date	Mar 20, 2026

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 27,425
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0874

Financial Performance

In 2024, HKG:0874's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY